Infectious disease
Infections clinical trials
Bacterial, viral, and other infections — from common illnesses to emerging threats. We’re tracking 4,178 recruiting studies in this area right now.
By phase
- Not applicable2,713
- Phase 2361
- Phase 4321
- Phase 1290
- Phase 3288
- Phase 1/Phase 2141
- Phase 2/Phase 364
Top conditions
Leading sponsors
- National Institute of Allergy and Infectious Diseases (NIAID)89
- Assistance Publique - Hôpitaux de Paris80
- University of California, San Francisco44
- Johns Hopkins University31
- Hospices Civils de Lyon30
- National Cancer Institute (NCI)28
- University of Washington27
- University Hospital, Strasbourg, France26
- Columbia University23
- University of Alabama at Birmingham23
Where studies are running
- California235
- Maryland146
- Alabama89
- New York76
- Florida74
- Texas61
- Massachusetts56
- Arizona47
- Pennsylvania45
- Illinois42
Recruiting studies4,178 total
- NCT07032363Recruiting
Depression and HIV treatment support study
This study tests a program that helps people with HIV manage depression and stick to their treatment. It's for adults in Cape Town, South Africa, who have a detectable HIV viral load or may have one, and who show signs of depression.
Miami, FloridaAges 18 years+ - NCT07033091Recruiting
HPV screening study for healthy adults 40 and older
This study checks healthy adults aged 40+ for HPV in the mouth using a simple gargle rinse. It aims to see if this can help find early signs of oropharyngeal cancer.
BrnoAges 40 years+ - NCT07035314Recruiting
Comparing medicines for pain after tonsil removal in children
This study compares two ways to manage pain after tonsil removal in children: a medication given by mouth or injection versus a medication applied directly to the surgical site. The goal is to find which approach works better for pain control.
CairoAges 4–10 - NCT07036159RecruitingPhase 2
Malaria vaccine safety study for children ages 5 months to 5 years
This trial tests a new malaria vaccine in healthy children. It aims to see if the vaccine is safe and how well it works in children who have had their regular childhood shots.
KigaliAges 5 months–5 years - NCT07038837RecruitingPhase 4
Comparing two ways to give the R21 malaria vaccine in Chad
This study tests two ways of giving the R21 malaria vaccine to children in Chad during the rainy season. One way follows the routine vaccination schedule, and the other gives the vaccine at the same time as seasonal malaria prevention medication.
Moïssala, Mandoul RegionAges 6 months–4.9 years - NCT07039019RecruitingEarly Phase 1
Prednisone for Non-Specific Pleuritis
This trial tests if a short course of the steroid prednisone can help people with nonspecific pleuritis—inflammation of the lung lining without a known cause. If you haven't responded to other treatments, this study aims to see if prednisone is a safe and effective option.
New York, New YorkAges 18 years+ - NCT07040202Recruiting
Immune responses in dengue and sepsis patients
This study looks at how the immune system responds to dengue fever and sepsis (a severe infection). It aims to better understand these illnesses, which could lead to improved treatments. If you have dengue-like symptoms, sepsis, or are a healthy volunteer, you may be able to join.
Kampong SpeuAges 2 years+ - NCT07040332Recruiting
Understanding allergic bronchopulmonary aspergillosis
This study looks at why some people with asthma get a lung infection from mold called aspergillus. It will help doctors better understand the condition and how to treat it.
Jinan, ShandongAges 18 years+ - NCT07040488Recruiting
Infrared camera study for diabetic foot in Guadeloupe
This study uses a special infrared camera to measure heat patterns in the feet of people with diabetes in Guadeloupe. The goal is to see if this painless method can help detect or monitor foot problems, which may prevent ulcers.
Pointe-à-PitreAges 18 years+ - NCT07044297RecruitingPhase 3
A study of a new long-acting shot to prevent HIV
This study tests an investigational long-acting shot (MK-8527) to prevent HIV. It is for HIV-negative people who are at higher risk through anal sex without condoms, and who have not used other long-acting HIV prevention before.
Birmingham, AlabamaAges 16 years+ - NCT07046988Recruiting
Terbinafine study for kids with scalp ringworm
This study looks at how the antifungal drug terbinafine works in children aged 2 to 18 who have tinea capitis (scalp ringworm). It aims to find the right dose to treat the infection effectively.
BeijingAges 2–18 - NCT07047053Recruiting
Shingles vaccine study for people with autoimmune diseases
This study looks at how well the shingles vaccine works in people with autoimmune inflammatory diseases. Researchers want to make sure the vaccine provides good protection for patients whose immune systems are affected by their condition or treatment.
ParisAges 18 years+ - NCT07048535Recruiting
Long-term follow-up study for CAR T-cell therapy patients
This study follows children and young adults who received CAR T-cell therapy for B-cell ALL at least two years ago. It checks long-term side effects, how well the therapy worked over time, and quality of life, so doctors can better understand the lasting impacts of CAR T-cells.
Memphis, TennesseeAges Any age - NCT07049159RecruitingPhase 2
Testing a new oral vaccine to prevent shigella and ETEC infection
This trial tests an oral vaccine designed to protect against two common causes of severe diarrhea: shigella and ETEC bacteria. Healthy adults aged 18 to 50 will receive the vaccine and later be exposed to the bacteria to see if it works.
Baltimore, MarylandAges 18–50 - NCT07050693Recruiting
Can a breast-milk sugar supplement prevent colds and stomach bugs?
This study tests a chewable supplement made from a natural sugar found in breast milk (2'-fucosyllactose) to see if it helps prevent colds and stomach bugs in young children who attend daycare or school. It is for healthy children between 1 and 4 years old.
Bari, BariAges 1–4 - NCT07051525Recruiting
Early vs. late stopping of antibiotics for fever in blood cancer treatment
This trial compares stopping antibiotics early (after fever resolves) versus continuing them as usual in adults with blood cancers who develop fever during treatment. It aims to find the best timing to reduce unnecessary antibiotic use.
Melbourne, VictoriaAges 18 years+ - NCT07051668Recruiting
Improving Sepsis Diagnosis in Pediatric Emergency Transfers
This study tests a new toolkit to help doctors better diagnose sepsis in children during emergency transfer calls. It looks back at records and call recordings to see if the toolkit improves how sepsis is spotted early.
Aurora, ColoradoAges 1 month+ - NCT07051694Recruiting
Ear nerve stimulation for sepsis patients in the ICU
This trial tests a non-invasive ear stimulation device (taVNS) as an extra treatment for sepsis in the ICU. It may help reduce inflammation and improve recovery.
ChongqingAges 18–80 - NCT07051954Recruiting
Breathing muscle training for long COVID recovery
This study tests a special breathing and muscle training program to help people with long COVID feel better and move more easily. The training is designed to strengthen the muscles you use to breathe and to improve your daily function.
Ankara, ÇankayaAges 18–65 - NCT07051967Recruiting
Comparing recovery after ICU for pregnant and non-pregnant COVID-19 patients
This study looks at how COVID-19 and respiratory failure affect recovery after intensive care. It compares pregnant patients to non-pregnant patients to learn more about the long-term effects.
BerlinAges 18 years+ - NCT07052162RecruitingPhase 4
Tafenoquine study in healthy Papua New Guinean children
This study tests how the malaria medicine tafenoquine works in healthy children in Papua New Guinea. It may help find the right dose to prevent malaria safely.
Madang, Madang ProvinceAges 5–12 - NCT07052604Recruiting
Antibiotic treatment for a rare pneumonia in ICU patients
This study looks at how well antibiotics work for pneumonia caused by a specific bacterium (Stenotrophomonas maltophilia) in patients who are on breathing machines in the intensive care unit (ICU). It will help doctors choose the best treatment.
Saint-Denis, FranceAges 18 years+ - NCT07054099RecruitingPhase 3
Testing a chickenpox vaccine for children ages 1 to 12
This study tests a new chickenpox vaccine (MG1111, also called BARYCELA Inj.) in healthy children aged 1 to 12 years. It checks how well the vaccine works and if it is safe, with two doses given over time.
Khon Kaen, Changwat Khon KaenAges 1–12 - NCT07054177Recruiting
Saliva test for gum disease in pregnancy
This study looks at how pregnancy and gum disease might change the chemicals in your saliva. By comparing pregnant women and non-pregnant women, researchers hope to find a simple way to screen for gum problems during pregnancy.
Istanbul, FatihAges 18–40
Common questions
- How many infections clinical trials are recruiting?
- Clin2 is tracking 4,178 recruiting infectious disease studies from the U.S. registry right now, out of 7,113 we cover in this area in total.
- What does “Infections” cover here?
- Bacterial, viral, and other infections — from common illnesses to emerging threats. We group each study into infections based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a infections trial near me?
- Use the search to filter infections studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.